| Literature DB >> 34947577 |
Gokul Paramasivam1, Vishnu Vardhan Palem1, Thanigaivel Sundaram1, Vickram Sundaram1, Somasundaram Chandra Kishore1, Stefano Bellucci2.
Abstract
Nanomaterials are endowed with unique features and essential properties suitable for employing in the field of nanomedicine. The nanomaterials can be classified as 0D, 1D, 2D, and 3D based on their dimensions. The nanomaterials can be malleable and ductile and they can be drawn into wires and sheets. Examples of nanomaterials are quantum dots (0D), nanorods, nanowires (1D), nanosheets (2D), and nanocubes (3D). These nanomaterials can be synthesized using top-down and bottom-up approaches. The achievements of 0D and 1D nanomaterials are used to detect trace heavy metal (e.g., Pb2+) and have higher sensitivity with the order of five as compared to conventional sensors. The achievements of 2D and 3D nanomaterials are used as diagnostic and therapeutic agents with multifunctional ability in imaging systems such as PET, SPECT, etc. These imaging modalities can be used to track the drug in living tissues. This review comprises the state-of-the-art of the different dimensions of the nanomaterials employed in theranostics. The nanomaterials with different dimensions have unique physicochemical properties that can be utilized for therapy and diagnosis. The multifunctional ability of the nanomaterials can have a distinct advantage that is used in the field of theranostics. Different dimensions of the nanomaterials would have more scope in the field of nanomedicine.Entities:
Keywords: CNT; bottom-up approach; diagnosis; graphene; nanocubes; nanomaterials; quantum dots; theranostics; therapy; top-down approach
Year: 2021 PMID: 34947577 PMCID: PMC8705396 DOI: 10.3390/nano11123228
Source DB: PubMed Journal: Nanomaterials (Basel) ISSN: 2079-4991 Impact factor: 5.076
Figure 1This figure shows a list of top-down and bottom-up approaches to synthesize nanomaterials. (a) Ball milling, (b) PVD, (c) CVD, (d) Lithography, (e) Sol-Gel method, and (f) Co-precipitation method.
Summarizes the list of zero-dimensional (0D) nanomaterials (e.g., quantum dots), their specification, and applications.
| S. No. | Nanomaterial | Elements | Size (nm) | Absorption (nm) | Functionalization | Application | Ref. |
|---|---|---|---|---|---|---|---|
| 1 | Quantum dots | CdSe, ZnS | <10 | 579 nm | Core/Shell-ZnS | Cd109-SPECT imaging agent incorporated for imaging and diagnostics to identify the tumour | [ |
| 2 | Quantum dots | CdTe, CdS, BSA | ~550 | λex = 400 nm | Protein (BSA) | QD-BSA was used for long term fluorescence observation because emission decreased by 4.06% after being irradiated at 365 nm for 1 h | [ |
| 3 | Carbon quantum dots | large amino acid-mimicking (LAAM), tetramino-anthraquinone (TAAQ), and citric acid | ~3 | 230 nm, 280 nm, 650 nm | α-carboxyl, amino groups | LAT-1-mediated targeting tumour theranostics | [ |
| 4 | Quantum dot | Mn, ZnS | 218 | 287 | Chitosan biopolymer and conjugated with folic acid | Diagnosis and treatment of anticancer activity of 5-fluorouracil for breast cancer therapy | [ |
| 5 | Quantum dot | In, P, Zn | 15–20 | 645 | Mercapto-succinic acid | This is a non-cadmium based QD used in diagnostic imaging in the early detection of cancer | [ |
Figure 2Scheme illustrates the intracellular uptake of QDs.
Summarizes the list of 1D nanomaterials employed in theranostics applications.
| S. No. | Nanomaterial | Elements | Size (nm) | Absorption (nm) | Functionalization | Application | Ref. |
|---|---|---|---|---|---|---|---|
| 1 | Nanorods | Au | 2.9–4.2 (aspect ratio) | 770–811 nm | Citrate, CTAB | Petawatts (PW) lasers are used to treat lung cancer cells instead of continuous wave (CW) lasers in theranostics. The laser energy used was 19 mJ/cm2. | [ |
| 2. | Nanowire | Magnetic polypyrrole, PEI, Antibody | 10 | --- | Biotin, Antibody | Magnetic nano wires are used to recover rare circulating biomarkers which improves cancer diagnostics and prognostics | [ |
| 3 | Nanowire | Au, Si | Au~500 nm, | 530 nm | Gold nanoparticles decorated on silicon nanowire | AuNP@SiNW acts as a NIR hyperthermia agent which destroys the cancer cells within 3 min upon NIR radiations | [ |
| 4. | Nanorods | Au, Si | 3–4 aspect ratio | AuNRs~600 nm | AuNRs functionalized with silica nanoparticles | Au@Si-Janus nanoparticles act as a carrier to deliver imaging agents and drugs. It also useful for combined photo-thermo or chemo cancer therapy | [ |
| 5 | Nanorods | Gd, Au | 20–40 | >750 nm | PEG functionalized Gd@AuNRs | Gd@AuNRs acts as a strong theranostics agent to image and treat MIAPaCa-2 cells. For NIR 808 lasers used and for MRI T1 features at 7T | [ |
Figure 3Represents the targeting of nanorods for theranostics.
Summarizes the list of 2D nanomaterials employed in theranostic applications.
| S. No. | Nanomaterial | Elements | Size (nm) | Absorption (nm) | Functionalization | Application | Ref. |
|---|---|---|---|---|---|---|---|
| 1 | MXene | Ti3C2 | 500 | 800 | --- | MXene acts as light to heat convert material with 100% efficiency in PTT | [ |
| 2 | Nanosheet | Boron nitride | 100 | 650 | Tannic acid (TA) | The TA-Fe coordinated complex on boron nitride nanosheet configuring T1 weighted MRI- Theranostics. It is also useful for MRI guided photo-therapy | [ |
| 3 | Nanosheet | Graphdiyne (GDY) | 360 | 700 | PEG | GDY-PEG acts as a photothermal-acoustic wave transducer in PAI and PTT for treating cancer | [ |
| 4 | Nanosheet | Graphene | 50 | --- | PEG, BPEI, DOX | The graphene oxide nanocomposites act as theranostics agents for UCL image-driven combinatorial PTT and chemotherapy to treat cancer. The NIR laser used at 980 nm with 13.5 photothermal conversion efficiency | [ |
| 5 | Nanosheet | (Gd3+)MoSe2 | 100–150 | 700–850 | PEG | Gd provides T1 weighted MR-imaging. (Gd3+)MoSe2 acts as photothermal agents in cancer therapy | [ |
Figure 4The scheme represents the application of 0D, 1D, 2D & 3D nanomaterials application in theranosis.